CORDIS - EU research results
CORDIS
Content archived on 2024-05-15

Prognostic value of upar forms in colon and breast cancer

Objective

Investigation of the clinical prognostic value of soluble urokinase plasminogen activator receptor (uPAR) forms in blood and tissue extracts from patients with colon and breast cancer, aiming to develop new methods which will aid in the decision-making needed in the management of cancer patients.

Call for proposal

Data not available

Coordinator

COPENHAGEN UNIVERSITY HOSPITAL
EU contribution
No data
Address
Stransboulevarden 49
2100 KOEPENHAGEN
Denmark

See on map

Total cost
No data